When Steve Jobs died, global attention turned to his cause of death – pancreatic cancer. Many people had questions: If someone of his wealth couldn’t beat this disease, can anyone? What many people may not know is that the eight years Jobs lived with his cancer diagnosis were significantly longer than the typical pancreatic cancer patient can expect to survive.
His survival was helped much, if not all to do with the particular type of pancreatic cancer that Jobs had.
There are two parts of the pancreas: the endocrine pancreas and the exocrine pancreas. Steve Jobs fell into the 1% of patients whose pancreatic cancer is of endocrine origin, and these patients have better chances of survival as endocrine pancreas are less aggressive. The other 99% of pancreatic cancer patients have exocrine tumors, most commonly in a form called an adenocarcinoma, and their prognosis is not so good: these tumors have a five-year survival rate of less than 5% compared to a 50 to 80% survival rate for endocrine tumors. Why is the outlook for adenocarcinomas so poor? It has everything to do with what happens before a patient ever makes a trip to the doctor.
How is pancreatic cancer detected?
You’ve been feeling abdominal pain for a few days, but you assume it’s just a stomach upset. However, when the symptoms persists, you decide to go in to see your doctor. The diagnosis: you have pancreatic cancer; your primary tumor is already quite large and has more than likely spread to other parts of the body – and you’re one of the luckier ones. The ability to detect pancreatic tumors can depend on which part of the pancreas the tumor originates from.
You will be somewhat lucky, if your pancreatic tumor is near the common bile duct, a buildup of bile in the blood can cause symptoms jaundice and that way the cancer can be detected early. People with pancreatic tumors originating elsewhere on the pancreas can go much longer before having any clue that something is wrong with them.
Because there are few, if any, symptoms in the early stages of pancreatic cancer, few patients are diagnosed early on, when surgery could be more useful because the cancer has not yet spread. Additionally, there are no general screening tools to catch pancreatic cancer early, in contrast to the regular mammograms used to detect breast cancer in women, for example. Even with some sort of early screening, pancreatic cancer can still go undetected by most imaging methods because of its location deep in the abdomen, beneath the liver and behind the stomach; it is known as “the hidden organ.”
How is pancreatic cancer treated?
The standard treatment for pancreatic cancer is chemotherapy. While the targets of chemotherapy include the fast-growing cancer cells, other tissues like hair and the lining of the gut are also harmed, which makes for unpleasant and potentially serious side effects for the patient.
A growing number of pancreatic cancer treatments in clinical trials work by helping our immune system specifically target and destroy cancer cells. These therapies use antibodies – molecules that are naturally produced by the immune system and bind to specific cells, marking them for destruction.
Another potential therapy in development for pancreatic cancer is the use of viruses to selectively target and kill cancer cells. The concept behind this therapy is that researchers can modify viruses to recognize molecules found exclusively in cancer cells. When such a virus is administered, it infects cancer cells and causes them to die, leaving normal tissues unharmed and spreading only to tumors. Clinical trials have been done in humans with virus-based therapies in recent years, and the results are promising.
Can we detect pancreatic cancer earlier?
Still, the difficulty in detecting pancreatic cancer in its early stages remains at the heart of why this disease is so deadly. One way to address this problem is by using improved imaging techniques, an area that has seen promising breakthroughs in recent years. One such technology involves the use of a simple endoscopy, in which a thin tube with a light at the end is passed into the upper part of the small intestine to see inside the body. This approach is based on the principle that a tumor in one part of the pancreas would alter the structure of the entire organ. Because the head of the pancreas is in contact with the upper intestine, an endoscopy could detect a meaningful change in pancreas structure early on in the cancer. An experiment showed this technique to be effective in identifying 19 out of 20 early-stage pancreatic tumors in patients.
Another cutting-edge imaging method under consideration takes advantage of a biomarker for early-stage pancreatic cancers. A biomarker is any biological substance that can be used to indicate a particular biological state; for example, a protein that is significantly more abundant in the blood of people with pancreatic cancer would be a biomarker for the disease. Identifying biomarkers for early-stage pancreatic cancers is an area of active study because they could make detecting these cancers much easier. Doctors could simply draw a blood sample and have an indication that a patient may have pancreatic cancer, at a time when the tumor is still operable. Fascinatingly, researchers at UCLA showed last year that they could detect biomarkers in saliva that were significantly different between people with pancreatic cancer and people who were only at risk for it. This noninvasive technology could be ideal for screening at-risk groups for pancreatic cancer, including people with chronic pancreatic inflammation and those with recent-onset diabetes.
The last few years have seen large strides in research to understand what sets pancreatic cancer apart, and to change how this disease is diagnosed and treated. These advances all provide hope for a future, perhaps only a few short years away, in which pancreatic cancer is not so silent a killer – or not as much of a killer at all.
Title – A title can be anything from a question, a heading of the article, or even the main topic about which you are publishing the post.
Description – It is explaining and adding the details about the topic you are posting. If you are asking a Question, then adding details is not necessary.
Photo, Video – You can attach a photo related to your post or can even publish a YOUTUBE video.
Sharing – Your name gets automatically attached behind the title of the article when you share is on Facebook or other platforms.
Eg: If a user John Watson have posted an article with the Title “How to handle Migraine without medicines?” and then if anyone share it on Facebook, the title will be like this :
“How to handle Migraine without medicines?”- John Watson
Themes of publishing or asking – You can publish from various themes that we mentioned and if any topic is missing among them, you can still post anything related to the Health. Healthcare is the only broad theme.